scorecardresearch
Tuesday, September 9, 2025
TopicAstraZeneca

Topic: AstraZeneca

Experimental drug shows promise in treatment of hard-to-control high blood pressure

AstraZeneca’s experimental drug baxdrostat cut systolic BP by nearly 10 mmHg in a late-stage trial, offering hope to patients at a high risk of heart attacks, among others.

Months after import duty waiver, GST slashed on same 3 anti-cancer drugs. Why this is little relief

Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs. 

AstraZeneca withdraws Covid vaccine worldwide, cites commercial reasons

Firm says vaccine has been superseded by updated ones that fight new variants & is no longer being made, supplied. Earlier, it had said its vaccine can cause a rare, dangerous side effect.

How safe is AstraZeneca Covid vaccine & why there is no need to panic — some key questions answered

51 cases have been lodged in a UK court against biopharma company over claims that its Covid vaccine caused death and injury in several cases.

Modi photo missing from Covid vaccine certificates due to model code, say health ministry officials

Prime Minister Narendra Modi’s photo was also removed from Covid-19 vaccination certificates issued in 5 poll-bound states in 2022 at EC's directions.

Don’t let anti-vaxxers weaponise AstraZeneca furore. Vaccines are safe—and we are the proof

Vaccines have eliminated two diseases—smallpox in humans and rinderpest in cattle. If they were killing one in 50,000 people, we wouldn’t be rolling them out across the globe for decades.

AstraZeneca vaccine safe, effective in kids, finds Lancet study. WHO still says for adults only

The vaccine, marketed as Covishield in India, induced antibody concentrations in children similar to those associated with high efficacy in adults, says study by UK researchers.

Covishield shows increased antibody response to Omicron after 3rd dose: AstraZeneca

Preliminary data released by AstraZeneca shows Vaxzevaria vaccine, administered in India as Covishield, increased immune response to Beta, Delta, Alpha, Gamma variants after third dose.

AstraZeneca’s antibody cocktail gets US nod for Covid prevention in those with low immunity

According to company Evusheld 'neutralises all previous SARs-CoV-2 variants to date'. AstraZeneca now intends to apply for approval in India.

Booster dose of 6 Covid vaccines is safe, increases immunity, shows study in Lancet

The study looked at safety, immune response and side-effects of seven vaccines — Oxford-AstraZeneca, Pfizer-BioNTech, Novavax, Janssen, Moderna, Valneva and Curevac.

On Camera

Is Nepal having a Bangladesh moment? Gen Z protests more than social media ban

Prime Minister KP Sharma Oli’s government is being called ‘Hatyara Sarkar’. Home Minister Ramesh Lekhak has resigned, but the protests continue to intensify.

What happens to Haryana real estate agents now? Govt agency HSVP to act as broker, take commissions

Gurugram: Stirring a storm in Haryana's real estate circles, the Haryana Shehri Vikas Pradhikaran (HSVP)—the state's urban development agency—has taken on the role of...

Modi to address military brass next week; theaterisation & Op Sindoor on agenda for Kolkata conference

The Combined Commanders’ Conference (CCC) in Kolkata is also likely to see deliberations on the proposed 'Sudarshan Chakra' missile defence system.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?